Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Braz. j. med. biol. res ; 52(10): e8324, 2019. tab, graf
Article in English | LILACS | ID: biblio-1039243

ABSTRACT

The aim of this study was to investigate the role of kinase-insert domain-containing receptor (KDR) in intrauterine adhesions (IUA) and its mechanism. The Case group consisted of 92 patients diagnosed with IUA, and the Control group included 86 patients with uterine septum who had normal endometrium verified with an uteroscope. In addition, 50 rats were randomly assigned into Control, Sham, Model, NC-siRNA, and KDR-siRNA groups. Rats in the Model, NC-siRNA, and KDR-siRNA groups were induced by uterine curettage and lipopolysaccharide (LPS) treatment to establish the IUA model. Then, immunohistochemistry was applied for detection of VEGF and KDR expression, HE staining was used for observation of the endometrial morphology and gland counting, Masson staining for measurement of the degree of endometrial fibrosis, and qRT-PCR and western blot for the expression of KDR, VEGF, MMP-9, as well as TGF-β1/Smads pathway-related proteins. Compared with the Control group, the mRNA and protein expressions of KDR were significantly higher in IUA endometrial tissues, and the expression of KDR was positively correlated to the severity of IUA. In addition, the injection of si-KDR increased the number of endometrial glands, reduced the area of fibrosis, inhibited mRNA and protein expression of KDR and VEGF, up-regulated the expression of MMP-9 and Smad7, and decreased the expression level of TGF-β1, p-Smad2, p-Smad3, and Smad4 in rats with IUA. Highly-expressed KDR was related to patients' severity of IUA, and silencing KDR may prevent the occurrence and development of IUA via TGF-β1/Smads signaling pathway and up-regulating the expression of MMP-9.


Subject(s)
Humans , Animals , Female , Adult , Middle Aged , Rats , Young Adult , Uterine Diseases/metabolism , Signal Transduction , Tissue Adhesions/metabolism , Vascular Endothelial Growth Factor Receptor-2/metabolism , Transforming Growth Factor beta1/metabolism , Uterine Diseases/pathology , Severity of Illness Index , Immunohistochemistry , Case-Control Studies , Tissue Adhesions/pathology , Blotting, Western , Rats, Wistar , Vascular Endothelial Growth Factor Receptor-2/genetics , Disease Models, Animal , Smad Proteins/genetics , Smad Proteins/metabolism , Transforming Growth Factor beta1/genetics , Real-Time Polymerase Chain Reaction
2.
Acta cir. bras ; 26(1): 51-57, jan.-fev. 2011. ilus, tab
Article in English | LILACS | ID: lil-572234

ABSTRACT

Purpose: To compare the effects of vitamin E and 1 percent methylen blue solutions on prevention of experimentally induced adhesions in rats. Methods: Thirty seven female Spraque Dawley rats were randomized into four groups. First group was kept as sham operated group. An adhesion model was constituted on the left uterine horn of the other groups. The lesion areas of rats from the second, the third and the fourth groups were coated with 2 ml 0.9 percent saline solution (C group), 10 mg vitamin E (VE group) and 1 percent methylen blue solutions (MB group), respectively. Results: Histopathologically, adhesion scores, mononuclear cell infiltration, oedema and fibrosis were more prominent in the MB group compared with C and VE groups. There were no significant differences between the groups in tissue glutathione peroxidase (GPx), catalase (CAT) activities and glutation (GSH) level, these parameters were slightly increased in group with VE supplementation though. The administration of VE and MB significantly decreased NO (P<0.01) levels when compared to the C group. The level of malondialdehyde (MDA) in the VE group was significantly lower (P<0.05) than those of the Sh and C groups. Conclusion: Intraperitoneal methylen blue solutions treatments were more effective according to vitamin E in preventing the formation of intra-abdominal adhesion in a rat uterine horn model.


Objetivo: Comparar os efeitos da vitamina E e 1 por cento da solução de azul de metileno na prevenção de aderências induzidas em ratos. Métodos: Trinta e sete ratos fêmeas Spraque Dawley foram distribuídos em quatro grupos. O primeiro grupo foi mantido como grupo sham. O modelo de aderência foi realizado no corno uterino esquerdo nos outros grupos. As áreas da lesão dos ratos do segundo, terceiro e quarto grupos foram revestidas com 2 ml de solução salina 0,9 por cento (Grupo C), 10 mg de vitamina E (Grupo VE) e solução de azul de metileno 1 por cento (Grupo MB), respectivamente. Resultados: Histopatologicamente, o escore das aderências, infiltração celular mononuclear, edema e fibrose foram mais proeminentes no grupo MB em comparação aos grupos C e VE. Não houve diferença significante entre os grupos na peroxidase da glutatione do tecido (GPx), atividade da catalase (CAT) e o nível de glutation (GSH). Estes parâmetros foram ligeiramente aumentados no grupo com suplemento da VE. A administração da VE e do MB diminuiu significantemente os níveis quando quando comparada ao Grupo C. O nível de malondialdeído no grupo VE foi significantemente mais baixo do que nos grupos sham e C. Conclusão: A administração intraperitoneal da solução de azul de metileno foi mais eficaz de acordo com a vitamina E na prevenção de aderências intra-abdominais no corno uterino de ratos.


Subject(s)
Animals , Female , Rats , Methylene Blue/therapeutic use , Postoperative Complications/prevention & control , Uterine Diseases/prevention & control , Vitamin E/therapeutic use , Vitamins/therapeutic use , Catalase/analysis , Glutathione Peroxidase/analysis , Glutathione/analysis , Lipid Peroxidation , Malondialdehyde/analysis , Nitric Oxide/analysis , Postoperative Complications/pathology , Random Allocation , Rats, Sprague-Dawley , Sodium Chloride/therapeutic use , Tissue Adhesions/etiology , Tissue Adhesions/pathology , Tissue Adhesions/prevention & control , Uterine Diseases/etiology , Uterine Diseases/metabolism
3.
Reprod. clim ; 11(4): 188-91, out.-dez. 1996. ilus, tab, graf
Article in Portuguese | LILACS | ID: lil-188466

ABSTRACT

OBJETIVOS: Observar as transformaçoes que ocorrem em fragmentos de membrana amniótica que foram utilizados para a confecçao de neovaginas em pacientes portadoras de agenesia útero-vaginal. CASUISTICA E METODOLOGIA: Foram 26 pacientes com agenesia utero-vaginal onde utilizou-se a técnica proposta por McIndoe. Para análise do epitélio da neovagina empregou-se método visando a determinaçao dos receptores de estrgênio citoplasmáticos (REc). Todos estes fragmentos de epitélio foram processados por método imunocitoquimico PAP (peroxidase x antiperoxidase). RESULTADOS: Estes receptores estrogênicos foram determinados em diversos graus de intensidade na camada profunda (CP), camada intermediária (CI) e na camada superficial (CS) dos epitélios de neovaginas. CONCLUSOES: O resultado obtido quanto ao grau de intensidade dos REc nas diversas camadas do epitélio vaginal de mulheres no menacme sao estatisticamente semelhantes e comparáveis no grau de intensidade aos fragmentos obtidos de epitélio de neovaginas confeccionadas com membrana amniótica.


Subject(s)
Humans , Female , Vaginal Diseases/metabolism , Epithelium/chemistry , Immunohistochemistry , Receptors, Estrogen/analysis , Vagina/abnormalities , Amnion/chemistry , Uterine Diseases/metabolism , Uterus/abnormalities
4.
Braz. j. med. biol. res ; 26(8): 853-7, Ago. 1993. tab
Article in English | LILACS | ID: lil-148757

ABSTRACT

We examined whether nitric oxide mediates estrogen-induced uterine edema in the immature rat. Immature Wistar rats (19-21 days) received estradiol-17 beta (E2) in a single sc dose of 10 micrograms/animal and 6 h later the animals were sacrificed and the changes in uterine wet and dry weights were determined. E2 treatment caused a 93 per cent increase in uterine wet weight (control, N = 6, 39.88 +/- 3.2 mg; E2 treated, N = 6, 76.8 +/- 4.9 mg), but not in dry weight, suggesting that it induces uterine edema. Pretreatment with L-nitroarginine methyl ester (L-NAME), a competitive antagonist of nitric oxide synthetase, at doses of 10 and 20 mg/kg, ip, caused a dose-related reduction (59 and 86 per cent ) in the uterine wet weight increase induced by E2. Furthermore, L-arginine (300-600 mg/kg, sc), the nitric oxide precursor, was able to reverse L-NAME (20 mg/kg)-induced decreases in uterine weight by 47 and 62 per cent , respectively. The results suggest that nitric oxide is the principal mediator involved in estrogen-induced uterine edema in the immature rat


Subject(s)
Animals , Female , Rats , Uterine Diseases/chemically induced , Edema/chemically induced , Nitric Oxide/physiology , Amino Acid Oxidoreductases/antagonists & inhibitors , Arginine/analogs & derivatives , Arginine/antagonists & inhibitors , Arginine/pharmacology , Uterine Diseases/metabolism , Uterine Diseases/pathology , Edema/metabolism , Edema/pathology , Enkephalin, Leucine-2-Alanine/analogs & derivatives , Enkephalin, Leucine-2-Alanine/pharmacology , Estradiol/administration & dosage , Organ Size , Rats, Wistar , Uterus
SELECTION OF CITATIONS
SEARCH DETAIL